Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medivolve Inc (COPRF)

Medivolve Inc (COPRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade COPRF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0073 +90.41%
on 10/03/22
0.0286 -51.40%
on 09/16/22
-0.0061 (-30.50%)
since 09/14/22
3-Month
0.0073 +90.41%
on 10/03/22
0.0327 -57.49%
on 07/29/22
-0.0094 (-40.34%)
since 07/14/22
52-Week
0.0073 +90.41%
on 10/03/22
0.2000 -93.05%
on 11/19/21
-0.0232 (-62.53%)
since 10/14/21

Most Recent Stories

More News
Medivolve Completes Previously Announced Private Placement Financing

Medivolve closes $12M in funding needed to support strategic plan including next phase of growth for AI technology platform that will change the face of human health management.

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Announces Private Placement Financing of up to $12 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Marbella Pharmacy Launches Vaccine Distribution in Orange County, California

Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Announces Rebrand, Affirms Momentum in Health-Tech Space Under New Leadership

New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Closes Acquisition of Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States

New platform supports Medivolve’s position as a growing health technology and services company

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Expands Portfolio of Pharmacy Acquisitions with Agreement to Acquire Outstanding Shares of CalVax Licensed Marbella Pharmacy

Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Announces an Investor Webinar Tuesday, May 11 at 11 am ET

TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC)  a healthcare company that seeks out disruptive technologies, ground-breaking innovations and...

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Signs Agreement to Acquire Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States

New platform supports Medivolve’s position as a growing health technology and services company

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve and Marvel Diagnostics Successfully Complete First Stage Clinical Testing of BlowFISH, a Non-Invasive Exhaled Breath Diagnostic Technology For COVID-19, Developed by a UCLA Research Team Led by Dr. Pirouz Kavehpour

Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology...

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)
Medivolve Announces Appointment of David Preiner as New Chief Executive Officer

TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC)  a healthcare investment management company that seeks out disruptive technologies, ground-breaking...

MEDV.NE : 0.0300 (+50.00%)
COPRF : 0.0139 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0166
2nd Resistance Point 0.0153
1st Resistance Point 0.0146
Last Price 0.0139
1st Support Level 0.0126
2nd Support Level 0.0113
3rd Support Level 0.0106

See More

52-Week High 0.2000
Fibonacci 61.8% 0.1264
Fibonacci 50% 0.1037
Fibonacci 38.2% 0.0809
Last Price 0.0139
52-Week Low 0.0073

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar